KRT7 and adenocarcinoma: If no pathological characteristic of a specific organ has been recognized, in adenocarcinomas, the expression of CK7/CK20, along with the sex and site of metastases, headed to the selection of specific IHC markers to define an alleged source tissue immunophenotype, which in turn guided targeted diagnostic investigations.